ID   K9TCC-PU-Nk
AC   CVCL_DN24
SY   K9TCC-NK
DR   Wikidata; Q54899444
RX   PubMed=18562222;
RX   PubMed=29732388;
CC   Doubling time: 58.4 +- 2.3 hours (PubMed=18562222).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350;
RA   Zuiverloon, Tahlita C.M.
RA   de Jong, Florus Christiaan
RA   Costello, James C.
RA   Theodorescu, Dan
RT   "Systematic review: characteristics and preclinical uses of bladder
RT   cancer cell lines.";
RL   Bladder Cancer 4:169-183(2018).
//
RX   PubMed=18562222; DOI=10.1016/j.urolonc.2008.02.015;
RA   Dhawan, Deepika
RA   Ramos-Vara, Jose A.
RA   Stewart, Jane C.
RA   Zheng, Rong
RA   Knapp, Deborah W.
RT   "Canine invasive transitional cell carcinoma cell lines: in vitro
RT   tools to complement a relevant animal model of invasive urinary
RT   bladder cancer.";
RL   Urol. Oncol. 27:284-292(2009).
//